MILESTONE SCIENTIFIC INC.

MILESTONE SCIENTIFIC INC. (MLSS) is a publicly traded US company. Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

The company reports net loss of $839,853.

Key metrics include a return on equity of -36.8%, a debt-to-equity ratio of 2.48.

Investors tracking MLSS can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.